/
JNJ
$255.68-$9.71 (-3.66%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$616.5B
2,410M shares
52-week range
$164.23 – $274.90
83% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
CS
Change+$83.55
Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
www.jnj.com- Employees
- 140,800
- IPO / List date
- Sep 25, 1944
- HQ
- NEW BRUNSWICK, NJ
Held by traders on TradeandTell
No one on the platform currently holds JNJ.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 696,884 | $170.3M |
| Renaissance Technologiesas of 2025-09-30 | 306,747 | $56.9M |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 2.07% ($5.28/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-08-25 | $1.3400 | 2026-09-08 |
| 2026-05-26 | $1.3400 | 2026-06-09 |
| 2026-02-24 | $1.3000 | 2026-03-10 |
| 2025-11-25 | $1.3000 | 2025-12-09 |
| 2025-08-26 | $1.3000 | 2025-09-09 |
| 2025-05-27 | $1.3000 | 2025-06-10 |
| 2025-02-18 | $1.2400 | 2025-03-04 |
| 2024-11-26 | $1.2400 | 2024-12-10 |
| 2024-08-27 | $1.2400 | 2024-09-10 |
| 2024-05-20 | $1.2400 | 2024-06-04 |
Recent trades on TradeandTell
No one on the platform has traded JNJ yet.
